Canertinib (Compound)

Synonyms:Canertinib, 267243-28-7, CI-1033, Canertinib (CI-1033), Canertinib free base, PD-183805, UNII-C78W1K5ASF, N-(4-(3-chloro-4-fluorophenylamino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide, N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide, C78W1K5ASF, CHEMBL31965, N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide, CHEBI:61399, 267243-28-7 (free base), N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(3-(morpholin-4-yl)propoxy)quinazolin-6-yl)prop-2-enamide, NCGC00182713-01, Canertinib [INN:BAN], CI-1033(Canertinib), CI1033, 6-acrylamido-N-(3-chloro-4-fluorophenyl)-7-(3-morpholinopropoxy)quinazolin-4-amine, CANETINIB, Canertinib (CI1033, Caneritinib; CI-1033, Canertinib - CI-1033, CI-1033 (Canertinib), DSSTox_CID_28869, DSSTox_RID_83138, DSSTox_GSID_48943, SCHEMBL54837, MLS004774146, PD 183805 dihydrochloride, BDBM4779, cid_156414, GTPL5675, DTXSID8048943, AOB6938, EX-A078, QCR-127, SYN1030, BCPP000301, HMS3244M17, HMS3244M18, HMS3244N17, BCP01790, Tox21_113361, NSC780019, NSC801011, s1019, ZINC27439698, AKOS005145818, BCP9000481, BCP9000482, BCP9000525, CCG-269588, CS-0121, DB05424, NSC-780019, NSC-801011, SB16594, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide, NCGC00182713-02, NCGC00182713-18, AS-56189, AT-17081, HY-10367, SMR003500789, AB0035841, PD0183805, CAS-267243-28-7, FT-0654215, Y0252, EC-000.2258, A25038, 32335-EP2281815A1, 32335-EP2292615A1, 32335-EP2301933A1, 32335-EP2305640A2, 32335-EP2305671A1, 32335-EP2311827A1, 499C452, Q5032274, CI-1033|||N-[4-(3-Chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide, N-[4-(3-chloro-4-fluoro-phenyl-amino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide

Id:156414

Description:nan